Caliber Imaging & Diagnostics
Private Company
Total funding raised: $25M
Overview
Caliber I.D. is a privately held medical technology company based in Rochester, NY, founded in 2008. It has developed and commercialized a proprietary platform of in vivo confocal microscopy devices, most notably the VivaScope systems, which enable non-invasive, real-time visualization of cellular morphology. The technology serves as a powerful adjunct to biopsy, aiding in the diagnosis of skin cancers like melanoma and improving surgical margin assessment. The company operates in the diagnostics and medical devices sectors, generating revenue through the sale of its imaging systems and related software and services.
Technology Platform
In vivo reflectance confocal microscopy (RCM) for non-invasive, real-time cellular-level imaging of skin and epithelial tissues.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Caliber I.D. competes with other non-invasive skin imaging devices like optical coherence tomography (OCT) systems and high-frequency ultrasound. It also competes indirectly with the standard of care—visual inspection and biopsy—and digital dermoscopy platforms. Its primary competitive advantage is the cellular-level resolution of confocal microscopy.